Position in PMVP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,625,835
-$936,392 QoQ
Shares Held
1,959,579
-31.8% QoQ
Ownership
3.67%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#8
of 64 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ArrowMark Colorado Holdings LLC holds $294,624,620 across 32 Biotechnology names. PMVP ranks #25 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
4,105,095 | $32,224,995 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
564,069 | $26,533,805 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
767,383 | $22,898,708 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
708,385 | $22,144,115 | |
| 5 | RPRX |
Royalty Pharma plc
|
366,199 | $20,532,777 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
46,030 | $15,410,383 | |
| 7 | ZBIO |
Zenas BioPharma, Inc.
|
573,318 | $14,550,810 | |
| 8 | CGON |
CG Oncology, Inc.
|
155,354 | $11,037,901 |
All Filings in PMVP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,625,835 | 1,959,579 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,562,227 | 2,872,764 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,862,616 | 3,090,093 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,621,877 | 3,301,341 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,379,402 | 3,188,116 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,606,457 | 3,308,677 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,297,761 | 3,508,451 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,434,463 | 3,647,291 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,543,746 | 2,804,782 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,437,885 | 3,198,756 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,413,843 | 2,714,143 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,660,415 | 270,426 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,692,866 | 270,426 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,290,905 | 899,561 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,395,369 | 964,985 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,465,597 | 879,462 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,848,390 | 831,466 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,833,026 | 568,349 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $12,550,345 | 543,305 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,717,116 | 527,420 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $14,795,652 | 433,128 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,993,622 | 395,063 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $24,149,318 | 392,608 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,200,000 | 400,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||